ImmunoPrecise Antibodies Ltd is a biotechnology business based in the US. ImmunoPrecise Antibodies shares (IPA) are listed on the NASDAQ and all prices are listed in US Dollars. ImmunoPrecise Antibodies employs 73 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in ImmunoPrecise Antibodies
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IPA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
ImmunoPrecise Antibodies stock price (NASDAQ: IPA)Use our graph to track the performance of IPA stocks over time.
ImmunoPrecise Antibodies shares at a glance
|Latest market close||$6.58|
|52-week range||$1.17 - $33.34|
|50-day moving average||$6.61|
|200-day moving average||$7.52|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.46|
Buy ImmunoPrecise Antibodies shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ImmunoPrecise Antibodies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ImmunoPrecise Antibodies price performance over time
|1 week (2021-10-08)||8.40%|
|1 month (2021-09-17)||-6.27%|
|3 months (2021-07-16)||21.18%|
|6 months (2021-04-16)||-34.85%|
|1 year (2020-10-16)||271.75%|
|2 years (2019-10-17)||1,683.68%|
|3 years (2018-10-17)||814.40%|
|5 years (2016-10-13)||N/A|
ImmunoPrecise Antibodies financials
|Revenue TTM||$18.7 million|
|Gross profit TTM||$11.4 million|
|Return on assets TTM||-11.88%|
|Return on equity TTM||-26.6%|
|Market capitalisation||$127.4 million|
TTM: trailing 12 months
Shorting ImmunoPrecise Antibodies shares
There are currently 448,182 ImmunoPrecise Antibodies shares held short by investors – that's known as ImmunoPrecise Antibodies's "short interest". This figure is 18.3% down from 548,823 last month.
There are a few different ways that this level of interest in shorting ImmunoPrecise Antibodies shares can be evaluated.
ImmunoPrecise Antibodies's "short interest ratio" (SIR)
ImmunoPrecise Antibodies's "short interest ratio" (SIR) is the quantity of ImmunoPrecise Antibodies shares currently shorted divided by the average quantity of ImmunoPrecise Antibodies shares traded daily (recently around 101169.751693). ImmunoPrecise Antibodies's SIR currently stands at 4.43. In other words for every 100,000 ImmunoPrecise Antibodies shares traded daily on the market, roughly 4430 shares are currently held short.
To gain some more context, you can compare ImmunoPrecise Antibodies's short interest ratio against those of similar companies.
However ImmunoPrecise Antibodies's short interest can also be evaluated against the total number of ImmunoPrecise Antibodies shares, or, against the total number of tradable ImmunoPrecise Antibodies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ImmunoPrecise Antibodies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ImmunoPrecise Antibodies shares in existence, roughly 20 shares are currently held short) or 0.0258% of the tradable shares (for every 100,000 tradable ImmunoPrecise Antibodies shares, roughly 26 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ImmunoPrecise Antibodies.
Find out more about how you can short ImmunoPrecise Antibodies stock.
ImmunoPrecise Antibodies share dividends
We're not expecting ImmunoPrecise Antibodies to pay a dividend over the next 12 months.
You may also wish to consider:
- Amgen (AMGN.US) (3.25% forward annual dividend yield)
Have ImmunoPrecise Antibodies's shares ever split?
ImmunoPrecise Antibodies's shares were split on a 1:5 basis on 22 November 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ImmunoPrecise Antibodies shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for ImmunoPrecise Antibodies shares which in turn could have impacted ImmunoPrecise Antibodies's share price.
ImmunoPrecise Antibodies share price volatility
Over the last 12 months, ImmunoPrecise Antibodies's shares have ranged in value from as little as $1.17 up to $33.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmunoPrecise Antibodies's is -0.1641. This would suggest that ImmunoPrecise Antibodies's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, ImmunoPrecise Antibodies has bucked the trend.
To put ImmunoPrecise Antibodies's beta into context you can compare it against those of similar companies.
ImmunoPrecise Antibodies overview
ImmunoPrecise Antibodies Ltd. , together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has a research collaboration agreement with Pierre Fabre S. A for antibody discovery. ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies in the news
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
ImmunoPrecise Antibodies announces at-the-market facility for up to $50M
Frequently asked questionsWhat percentage of ImmunoPrecise Antibodies is owned by insiders or institutions?
Currently 6.858% of ImmunoPrecise Antibodies shares are held by insiders and 7.475% by institutions. How many people work for ImmunoPrecise Antibodies?
Latest data suggests 73 work at ImmunoPrecise Antibodies. When does the fiscal year end for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies's fiscal year ends in April. Where is ImmunoPrecise Antibodies based?
ImmunoPrecise Antibodies's address is: 3204?4464 Markham Street, Victoria, BC, Canada, V8Z 7X8 What is ImmunoPrecise Antibodies's ISIN number?
ImmunoPrecise Antibodies's international securities identification number is: CA45257F2008
More guides on Finder
How to buy Aura Biosciences (AURA) stock when it goes public
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
How to buy Claros Mortgage Trust (CMTG) stock when it goes public
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
How to buy Evotec SE (EVO) stock when it goes public
Everything we know about the Evotec SE IPO, plus information on how to buy in.
How to buy Delimobil Holding SA (DMOB) stock when it goes public
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
How to buy Blue Water Vaccines (BWV) stock when it goes public
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
How to buy Sonendo (SONX) stock when it goes public
Everything we know about the Sonendo IPO, plus information on how to buy in.
How to buy FlexEnergy Green Solutions (FLXE) stock when it goes public
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
How to buy Stran & Company (STRN) stock when it goes public
Everything we know about the Stran & Company IPO, plus information on how to buy in.
How to buy Kidpik Corp (PIK) stock when it goes public
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
How to buy Nuvectis Pharma (NVCT) stock when it goes public
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
Ask an Expert